NCT04758676

Brief Summary

The aim of the study is to monitor and evaluate changes in body composition, with a special emphasis on muscle mass, in the context of polyneuromyopathy of critically-ill patients at ICU, on artificial ventilation (duration of artificial ventilation at least 7 days), and subsequent comparison with the patient's condition in 12 weeks, as a part of Post-Intensive Care Syndrome (PICS) monitoring. The effect of the package (nutritional recommendations + physiotherapy protocol vs. standard of care) will be evaluated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable sepsis

Timeline
Completed

Started Mar 2021

Longer than P75 for not_applicable sepsis

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 17, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 29, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2024

Completed
Last Updated

January 18, 2024

Status Verified

January 1, 2024

Enrollment Period

3 years

First QC Date

January 14, 2021

Last Update Submit

January 17, 2024

Conditions

Keywords

polymyoneuropathybioelectric impedancepost-intensive care syndromemultiple organ dysfunction

Outcome Measures

Primary Outcomes (1)

  • Body composition

    Body composition will be studied using bioimpedance analysis - comparison of skeletal muscle mass, fats, body fluids

    12 weeks

Secondary Outcomes (5)

  • Changes in the albumin level

    12 weeks

  • Changes in the prealbumin level

    12 weeks

  • Changes in the C-reactive protein (CRP) level

    12 weeks

  • Changes in the presepsin level

    12 weeks

  • Comparison of muscle functions

    12 weeks

Other Outcomes (4)

  • Functional limitations - time up and go test (TUG)

    12 weeks

  • Functional limitations - spirometry - forced vital capacity (FCV)

    12 weeks

  • Functional limitations - spirometry - forced expiratory velocity (FEV1)

    12 weeks

  • +1 more other outcomes

Study Arms (2)

Nutritional and physiotherapy protocol, BIA

EXPERIMENTAL

Study subjects randomized into this study arm will be indicated for nutritional and physiotherapy protocol, based upon the obtained results of the measurements, using bioimpedance analysis.

Other: Nutritional and physiotherapy protocol, BIA

Standard of care

ACTIVE COMPARATOR

Study subjects randomized into this study arm will be provided the current standard of care.

Other: Standard of care

Interventions

Study subjects will be treated using the nutritional and physiotherapy protocol, based upon the results of measurements, using bioimpedance analysis.

Nutritional and physiotherapy protocol, BIA

Study subjects will receive the current standard of care.

Standard of care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with respiratory insufficiency
  • Expected period of artificial ventilation of 7 days
  • Acute lung injury (ALI)
  • Acute respiratory distress syndrome (ARDS)
  • Acute exacerbation of chronic obstructive pulmonary disease (COPD)
  • Signed informed consent (may be signed by witnesses, if the patient is unconscious)

You may not qualify if:

  • Patients with unfavorable prognosis for 12-week follow-up
  • APACHE Score \>30
  • Metastasizing malignity
  • Patients after cardiopulmonary resuscitation (CPR) prior to admission
  • Cerebral edema
  • Cerebral trauma
  • Intracranial hypertension
  • Liver cirrhosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Ostrava, Department of Physiology and Patophysiology

Ostrava, Moravian-Silesian Region, 70300, Czechia

RECRUITING

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, 70852, Czechia

RECRUITING

Related Publications (1)

  • Kanova M, Petrekova K, Borzenko N, Ruskova K, Nytra I, Dzurnakova P, Burda M, Konvicka J. Bioelectrical Impedance in Monitoring Hyperhydration and Muscle Wasting in Critically Ill Corona Virus Disease (COVID-19) Patients: The Feasibility of Predicting Outcome. Physiol Res. 2025 Dec 31;74(Suppl 1):S93-S106.

MeSH Terms

Conditions

SepsisWounds and InjuriesRespiratory Insufficiencypostintensive care syndrome

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsRespiration DisordersRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Marcela Káňová, MD, Ph.D.

    University Hospital Ostrava

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jiří Hynčica

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No masking is used in the study
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: There are two arms in the study - experimental group (diagnostics with the Multiscan 5000 device, nutritional recommendations, physiotherapy protocol), and control group (standard of care)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2021

First Posted

February 17, 2021

Study Start

March 1, 2021

Primary Completion

February 29, 2024

Study Completion

May 31, 2024

Last Updated

January 18, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

There is no plan to make individual participant data available to other researchers.

Locations